Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Low-Dose Antithymocyte Globulin for Treatment of Steroid-Pulse-Resistant Acute Graft-versus-Host Disease

  • 51 Accesses

  • 6 Citations

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Nash RA, Antin JH, Karanes C, et al. Phase 3 study comparing methotrexate and tacrolimus with methotorexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors.Blood. 2000;96:2062–2068.

  2. 2.

    Deeg HJ, Loughran TP Jr, Storb R, et al. Treatment of human acute graft-versus-host disease with antithymocyte globulin and cyclosporine with or without methylprednisolone.Transplantation. 1985; 40:162–166.

  3. 3.

    Basara N, Kiehl MG, Blau W, et al. Mycophenolate Mofetil in the treatment of acute and chronic GVHD in hematopoietic stem cell transplant patients: four years of experience.Transplant Proc. 2001; 33:2121–2123.

  4. 4.

    Racadot E, Milpied N, Bordigoni P, et al. Sequential use of three monoclonal antibodies in corticosteroid-resistant acute GVHD: a multicentric pilot study including 15 patients.Bone Marrow Transplant. 1995;15:669–677.

  5. 5.

    Dugan MJ, DeFor TE, Steinbuch M, et al. ATG plus corticosteroid therapy for acute graft-versus-host disease: predictors of response and survival.Ann Hematol. 1997;75:41–46.

  6. 6.

    McCaul KG, Nevill TJ, Barnett MJ, et al. Treatment of steroid- resistant acute graft-versus-host disease with rabbit antithymocyte globulin.J Hematother Stem Cell Res. 2000;9:367–374.

  7. 7.

    Khoury H, Kashyap A, Adkins DR, et al. Treatment of steroid- resistant acute graft-versus-host disease with anti-thymocyte globulin.Bone Marrow Transplant. 2001;27:1059–1064.

  8. 8.

    Rowlings PA, Przepiorka D, Klein JP, et al. IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade.Br J Haematol. 1997;97:855–864.

Download references

Author information

Correspondence to Kazuteru Ohashi or Yuji Tanaka or Shin-ichiro Mori or Yoshiki Okuyama or Kiyoshi Hiruma or Hideki Akiyama or Hisashi Sakamaki.

About this article

Cite this article

Ohashi, K., Tanaka, Y., Mori, S. et al. Low-Dose Antithymocyte Globulin for Treatment of Steroid-Pulse-Resistant Acute Graft-versus-Host Disease. Int J Hematol 77, 99–102 (2003). https://doi.org/10.1007/BF02982612

Download citation

Keywords

  • FK506
  • Mycophenolate Mofetil
  • Antithymocyte Globulin
  • Hematopoietic Stem Cell Transplant Patient
  • Stem Cell Transplant Patient